Arbaz 60mg Injection

About

Arbaz 60mg Injection is an anticoagulant medication primarily used to prevent and treat various thromboembolic disorders. It belongs to a class of drugs that work by inhibiting specific clotting factors in the blood, thereby reducing the blood's ability to form clots. This action is crucial in conditions where there is an increased risk of clot formation, such as deep vein thrombosis (DVT) and pulmonary embolism (PE), or during certain medical procedures and surgeries. By preventing the formation and growth of blood clots, Arbaz helps to maintain blood flow, reduce the risk of serious complications like stroke or heart attack, and improve patient outcomes. It is administered via subcutaneous injection, providing a predictable anticoagulant effect.

Uses

• Prevention of deep vein thrombosis (DVT) in surgical patients.
• Treatment of established deep vein thrombosis and pulmonary embolism.
• Prevention of DVT in acutely ill medical patients.
• Prevention of clotting during hemodialysis.

Directions For Use

Administer subcutaneously into the abdominal wall or thigh, as directed by a healthcare professional. Do not inject intramuscularly.

Benefits

• Effectively prevents blood clot formation.
• Treats existing deep vein thrombosis.
• Reduces risk of pulmonary embolism.
• Provides predictable anticoagulant effect.
• Subcutaneous administration for ease of use.
• Lowers risk of cardiovascular complications.

Side Effects

• Bleeding (e.g., bruising, nosebleeds)
• Injection site pain or bruising
• Thrombocytopenia (low platelet count)
• Allergic reactions (rash, itching)
• Elevated liver enzymes
• Osteoporosis (with long-term use)
• Headache
• Nausea
• Vomiting
• Diarrhea
• Fever
• Spinal or epidural hematoma (rare, serious)

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it may increase the risk of bleeding.
• Pregnancy - Generally considered safe for use during pregnancy when indicated, but consult a physician.
• Breastfeeding - Considered compatible with breastfeeding, as it is unlikely to pass into breast milk in significant amounts.
• Liver - Use with caution in severe hepatic impairment due to increased bleeding risk; monitor coagulation parameters.
• Kidney - Dose adjustment may be necessary in patients with severe renal impairment; monitor closely.
• Lung - Use with caution in patients with active pulmonary hemorrhage or conditions predisposing to bleeding.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.